Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Why am I not surprised? Teens who abuse drugs don’t stop as adults

Posted on April 5, 2022 by Devon Herrick

Once teenage drug users reach adulthood are they safely past the likelihood of future drug abuse? No, not according to research. A study followed 5,300 teens all the way to age 50.

+

Should the FDA Require Proof that High-Priced Drugs Actually Work?

Posted on April 4, 2022April 4, 2022 by Devon Herrick

An advisory committee at the U.S. Food and Drug Administration (FDA) recently voted against fast-track approval for an experimental drug to treat amyotrophic lateral sclerosis (ALS). ALS is also known as Lou Gehrig’s disease. You can watch the committee meeting, and learn more, in this post.

+

What Happens When Seniors’ Share of Drug Costs Goes Down?

Posted on March 16, 2022March 21, 2022 by John C. Goodman

The change: Under the ACA, the coinsurance rate in the “donut hole” is being reduced from 100% in 2011 to 25% in 2022.

The results: No change in drug use. No change in total spending. But seniors did switch from generic to brand drugs more often.

Click her to view/download the Study

HT: Jason Shafrin

+

When is an FDA-Approved Drug Not a Drug?

Posted on March 14, 2022March 21, 2022 by Devon Herrick

In 2018 the Centers for Medicare and Medicaid Services (CMS) suddenly removed Auryxia (ferric citrate) from the Medicare Part D drug formulary and began to require prior authorization for the few indications it would reimburse. CMS gave little information about the reversal but apparently made the decision because it views ferric citrate at a mineral product, like dietary supplements such as Vitamin C. Dietary supplements are not covered by Medicare except in a few cases.

+
  • Previous
  • 1
  • …
  • 245
  • 246
  • 247
  • 248
  • 249
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom